Nu-Med Plus (NUMD) EBITDA (2012 - 2026)
Nu-Med Plus' (NUMD) quarterly EBITDA came in at -$22556.0 in Q2 2026, down 116.49% year-over-year from $136793.3 in Q2 2025, and down 131.08% quarter-over-quarter from -$9761.0 in Q4 2025.
Powered by 
Analysis
Nu-Med Plus (NUMD) EBITDA (2012 - 2026) Analysis & Trends
Nu-Med Plus has disclosed EBITDA across 15 years of filings, most recently posting -$22556.0 for Q2 2026.
- In Q2 2026, EBITDA fell 116.49% year-over-year to -$22556.0; the TTM figure through Jun 2026 stood at -$52811.0 (up 5.41% YoY), while the FY2025 annual figure was -$48955.0, up 22.7% from the prior year.
- EBITDA came in at -$22556.0 for Q2 2026 at Nu-Med Plus, down from -$9761.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$6394.0 in Q4 2022 to a low of -$58070.0 in Q2 2022.
- Average EBITDA over 5 years is -$25618.8, with a median of -$18700.0 recorded in 2025.
- Year-over-year, EBITDA soared 94.17% in 2022 and sank 765.44% in 2023.
- Over 5 years, EBITDA stood at -$6394.0 in 2022, then slumped by 765.44% to -$55336.0 in 2023, then soared by 83.2% to -$9294.0 in 2024, then retreated by 5.02% to -$9761.0 in 2025, then plunged by 131.08% to -$22556.0 in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$22556.0 in Q2 2026, -$9761.0 in Q4 2025, and -$10075.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -22,556.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22,556.00 |
| Dec 31, 2025 | -9,761.00 |
| Sep 30, 2025 | -10,075.00 |
| Jun 30, 2025 | -10,419.00 |
| Mar 31, 2025 | -18,700.00 |
| Dec 31, 2024 | -9,294.00 |
| Sep 30, 2024 | -17,417.00 |
| Jun 30, 2024 | -16,040.00 |
| Mar 31, 2024 | -20,579.00 |
| Dec 31, 2023 | -55,336.00 |
| Sep 30, 2023 | -15,146.00 |
| Jun 30, 2023 | -23,073.00 |
| Mar 31, 2023 | -26,971.00 |
| Dec 31, 2022 | -6,394.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -57,638.00 |
| Dec 31, 2021 | -109,691.00 |
| Sep 30, 2021 | -115,717.00 |
| Jun 30, 2021 | -250,573.00 |